Sort
64,565 grants matching “drug discovery”
Kianse Networks Controling Flavivirus Replication
$664,617Klaus J Frueh · Oregon Health & Science University · U54 · FY2009 · AI
Mycobacterium tuberculosis antigen diversity
$664,613Joel D. Ernst · New York University School Of Medicine · R01 · FY2010 · AI
Multimodal Retinal Functional Imaging for Diabetic Retinopathy
$664,612Shuliang Jiao · University Of Southern California · R01 · FY2011 · EY
Antimicrobial evaluation and development
$664,543Kim Lewis · Northeastern University · P01 · FY2020 · AI
Tuberculosis epidemiology and novel transmission routes in rural Tanzania
$664,540Philip C Hopewell · University Of California, San Francisco · U01 · FY2010 · AI
High-Throughput Solid-Phase Combinatorial Biocatalysis
$664,467Jonathan S. Dordick · Rensselaer Polytechnic Institute · R01 · FY2007 · GM
Blood Brain Barrier Changes Induced by Pain
$664,448Thomas Paul Davis · University Of Arizona · R01 · FY2010 · NS
Development of therapeutic GABA-producing bacteria
$664,418Philip Peter Strandwitz · Holobiome, Inc. · R44 · FY2020 · DK
Hydrogel Particle-Based microRNA Profiling for Discovery and Cancer Diagnostics
$664,407Daniel Pregibon · Firefly Bioworks, Inc. · R44 · FY2012 · CA
Control of Tsetse Fly Transmitted Diseases in Kenya
$664,374Serap Aksoy · Yale University · U01 · FY2017 · AI
Genetics of extracellular matrix in health and disease
$664,358Zsolt Urban · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · HL
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2019 · DK
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2021 · DK
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2018 · DK
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2020 · DK
Genetic Analysis of Attention Deficit Hyperactivity Disorder
$664,105Maximilian Muenke · National Human Genome Research Institute · ZIA · FY2013 · HG
Development of SMAC mimetics as latency-reversing agents
$664,048Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · AI
Development of SMAC mimetics as latency-reversing agents
$664,048Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · AI
Development of SMAC mimetics as latency-reversing agents
$664,048Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AI
Development of SMAC mimetics as latency-reversing agents
$663,969Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · AI
ALCOHOL DEPENDENCE IN AFRICAN AMERICANS: A CASE-CONTROL GENETIC STUDY
$663,948Richard A Grucza · Washington University · R01 · FY2010 · AA
Mycobacterial DNA repair and mutagenesis
$663,906Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2023 · AI
Mycobacterial DNA repair and mutagenesis
$663,906Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2021 · AI
Mycobacterial DNA repair and mutagenesis
$663,906Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2022 · AI
Mycobacterial DNA repair and mutagenesis
$663,906Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2024 · AI